FADI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 819
AS - Asia 207
EU - Europa 102
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.131
Nazione #
US - Stati Uniti d'America 819
CN - Cina 123
SG - Singapore 56
FI - Finlandia 27
VN - Vietnam 22
UA - Ucraina 19
SE - Svezia 14
DE - Germania 12
IT - Italia 11
FR - Francia 8
GB - Regno Unito 8
EU - Europa 3
IE - Irlanda 3
IQ - Iraq 3
HK - Hong Kong 2
AZ - Azerbaigian 1
Totale 1.131
Città #
Woodbridge 114
Ann Arbor 110
Chandler 102
Jacksonville 81
Ashburn 65
Houston 49
Singapore 46
Santa Clara 35
Wilmington 27
Beijing 26
Des Moines 26
Dong Ket 22
Fairfield 21
Cambridge 20
Boardman 19
Medford 16
Princeton 16
Nanjing 15
Helsinki 11
Hebei 7
Nanchang 6
Redwood City 6
Seattle 6
Jinan 5
Shenyang 5
Zhengzhou 5
New York 4
Tianjin 4
Dublin 3
Harringay 3
Los Angeles 3
Padova 3
Changsha 2
Guangzhou 2
Haikou 2
Hong Kong 2
Lanzhou 2
London 2
Mestre 2
Baku 1
Bologna 1
Bristol 1
Hangzhou 1
Hefei 1
Jiaxing 1
Kunming 1
Munich 1
Norwalk 1
Racine 1
Redmond 1
Rockville 1
San Diego 1
Shanghai 1
Simi Valley 1
Stamford 1
Trieste 1
Yellow Springs 1
Totale 913
Nome #
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 93
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 91
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 89
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 87
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 80
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 78
NT-S100A8 effects on cell signalling. 74
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 73
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 71
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 68
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 66
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 66
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 59
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 51
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 45
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 41
Totale 1.132
Categoria #
all - tutte 3.479
article - articoli 339
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 0 9 7 12 10 54 4 8
2020/202197 0 8 1 7 2 10 4 9 10 5 15 26
2021/2022100 0 30 0 7 0 6 2 4 3 1 12 35
2022/2023210 29 29 0 28 26 46 1 15 26 6 3 1
2023/2024116 5 11 5 7 3 5 13 41 3 4 6 13
2024/2025140 1 14 26 26 72 1 0 0 0 0 0 0
Totale 1.132